IPI24: An International Study To Create An IPI For The Event-Free Survival At 24 Months (EFS24) Endpoint For DLBCL In The Immunochemotherapy Era
Year: 2013
Type: conference-abstract
Source: Blood
Authors: Matthew J Maurer, Herve Ghesquieres, Jean-Philippe Jais, Thomas E Witzig, Corinne Haioun, Carrie A Thompson, Richard Delarue, Ivana N. Micallef, Frederic Peyrade, William R Macon, Thierry Jo Molina, Nicolas Ketterer, Sergei I Syrbu, Olivier Fitoussi, Paul J Kurtin, Cristine Allmer, Emmanuelle Nicolas-Virelizier, Susan L Slager, Thomas M Habermann, Brian K Link, Gilles Andre Salles, Herve Tilly, James R Cerhan
Institutions: Mayo Clinic, Centre National de la Recherche Scientifique, Laboratoire de Biologie et Modélisation de la Cellule, Centre Léon Bérard, Hôpital Necker-Enfants Malades, Centre Hospitalier Universitaire Henri-Mondor, Hôpitaux Universitaires Henri-Mondor, Centre Antoine Lacassagne, Assistance Publique – Hôpitaux de Paris, Hôtel-Dieu de Paris, Université Paris Descartes, Centre Hospitalier Universitaire Vaudois, University of Iowa, Lyon 1 Université, Hospices Civils de Lyon, Centre Henri Becquerel
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2551221750